Reuters: Health
Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp produced positive results in a clinical trial.
| submitted by /u/BlankVerse [link] [comments] |
| submitted by /u/Express_Hyena [link] [comments] |
Subscribe UsPopular Posts
|